RAC 2.20% $1.78 race oncology ltd

General Comments / Chat, page-7642

  1. 139 Posts.
    lightbulb Created with Sketch. 33
    I wonder why people assume it is FTO versus cardio protection as it was DTs hypothesis on cardio protection and formulation of clinical trials to prove as CSO. I think the answer is elsewhere on this one and probably comes down to other strategy either for shareholder value (which he seemed passionate about) or related to his role as CSO.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.